The IVI Board of Directors is comprised of members representing various classes of stakeholders, including research and academia, providers, patients, payers, pharmaceutical and medical device companies, as well as other companies in the healthcare industry. The Board is responsible for overseeing the financial and strategic direction of the organization and provides advice and leadership support to IVI’s Executive Director and staff team to execute its work.

Board Members

Alan Balch

Patient Advocate Foundation

John Banta

BlueCross BlueShield Venture Partners

Harold Carter

Express Scripts

Chuck Cutler

Cutler Healthcare

Mark Cziraky (President Elect)


Greg Daniel (Immediate Past President)

Eli Lilly and Company

Patty Fritz (Secretary/Treasurer)

UCB, Inc.

Nelly Ganesan

JPMorgan Chase & Co. – Morgan Health

Suzanne Schrandt


Vipan Sood

CSL Vifor

Adam Thompson

Independent Consultant

Michael Thompson (President)

National Alliance of Healthcare Purchaser Coalitions

Ashley Valentine

Sick Cells

Neil Weissman

MedStar Health Research Institute